Does IMIPENEM Cause Off label use? 202 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 202 reports of Off label use have been filed in association with IMIPENEM. This represents 10.8% of all adverse event reports for IMIPENEM.
202
Reports of Off label use with IMIPENEM
10.8%
of all IMIPENEM reports
74
Deaths
110
Hospitalizations
How Dangerous Is Off label use From IMIPENEM?
Of the 202 reports, 74 (36.6%) resulted in death, 110 (54.5%) required hospitalization, and 25 (12.4%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IMIPENEM. However, 202 reports have been filed with the FAERS database.
What Other Side Effects Does IMIPENEM Cause?
Drug ineffective (351)
Condition aggravated (138)
Vomiting (137)
Drug resistance (117)
Nausea (111)
Dyspnoea (97)
Diarrhoea (90)
Pyrexia (90)
Product use in unapproved indication (85)
Thrombocytopenia (84)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which IMIPENEM Alternatives Have Lower Off label use Risk?
IMIPENEM vs IMIPRAMINE
IMIPENEM vs IMIQUIMOD
IMIPENEM vs IMITREX
IMIPENEM vs IMMUNE GLOBULIN NOS
IMIPENEM vs IMPLANON